ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 200 filers reported holding ARGENX SE in Q1 2022. The put-call ratio across all filers is 0.51 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,668,101 | +12.0% | 3,393 | -11.2% | 2.15% | +20.0% |
| Q2 2023 | $1,489,158 | +5.0% | 3,821 | +0.4% | 1.79% | -8.7% |
| Q1 2023 | $1,417,667 | -51.5% | 3,805 | -50.7% | 1.96% | -30.1% |
| Q4 2022 | $2,924,189 | +12.9% | 7,719 | +5.2% | 2.81% | +12.7% |
| Q3 2022 | $2,591,000 | -10.3% | 7,338 | -3.8% | 2.49% | -20.8% |
| Q2 2022 | $2,890,000 | -34.2% | 7,628 | -45.2% | 3.15% | +3.1% |
| Q1 2022 | $4,391,000 | -48.2% | 13,925 | -42.4% | 3.05% | -25.0% |
| Q4 2021 | $8,473,000 | +82.1% | 24,196 | +57.0% | 4.07% | +97.0% |
| Q3 2021 | $4,654,000 | +23.0% | 15,410 | +22.7% | 2.06% | +18.3% |
| Q2 2021 | $3,783,000 | +25.8% | 12,564 | +15.1% | 1.74% | -1.8% |
| Q1 2021 | $3,006,000 | +16.2% | 10,917 | +24.1% | 1.78% | -9.9% |
| Q4 2020 | $2,587,000 | – | 8,798 | – | 1.97% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 39,370 | $14,917,000 | 13.60% |
| Tri Locum Partners LP | 82,735 | $31,347,000 | 12.84% |
| Avoro Capital Advisors LLC | 1,265,555 | $479,493,000 | 9.48% |
| Artal Group S.A. | 400,000 | $151,552,000 | 8.10% |
| Finepoint Capital LP | 52,800 | $20,005,000 | 6.92% |
| Paradigm Biocapital Advisors LP | 88,816 | $33,651,000 | 6.71% |
| Fairmount Funds Management LLC | 73,526 | $27,858,000 | 6.38% |
| DCF Advisers, LLC | 25,000 | $9,472,000 | 5.64% |
| Redmile Group, LLC | 385,818 | $146,179,000 | 5.58% |
| Eagle Health Investments LP | 60,300 | $22,846,000 | 5.33% |